Uploaded August 2026 | Updated September 2026, 1 week ago
How Is AI Reshaping Innovative Drug Development? Alex Zhavoronkov in Conversation with CGTN
From artificial intelligence and robotics to next-generation biotechnology, China’s “new new trio” is accelerating convergence across these fields.
In an exclusive interview with CGTN, Alex Zhavoronkov, Founder and CEO of Insilico Medicine, discusses how generative AI is improving the efficiency of drug discovery, advancing innovative drug development, and exploring the unique strengths of China’s biotechnology industry.
In the face of aging and disease—shared challenges for all humanity—what truly matters is not competition alone, but global collaboration, ensuring that technological progress ultimately benefits everyone.
How Is AI Reshaping Innovative Drug Development? Alex Zhavoronkov in Conversation with CGTN
From artificial intelligence and robotics to next-generation biotechnology, China’s “new new trio” is accelerating convergence across these fields.
In an exclusive interview with CGTN, Alex Zhavoronkov, Founder and CEO of Insilico Medicine, discusses how generative AI is improving the efficiency of drug discovery, advancing innovative drug development, and exploring the unique strengths of China’s biotechnology industry.
In the face of aging and disease—shared challenges for all humanity—what truly matters is not competition alone, but global collaboration, ensuring that technological progress ultimately benefits everyone.
